<?xml version="1.0" encoding="UTF-8"?>

<article>
<articleinfo>
<bibliomisc>MEDLINE:99223566</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="retinoid_X_receptor_(RXR)_agonist-induced_activation" sem="G#other_name"><cons lex="retinoid_X_receptor" sem="G#protein_molecule"><w c="NN">Retinoid</w> <w c="NN">X</w> <w c="NN">receptor</w></cons> <w c="(">(</w><cons lex="RXR" sem="G#protein_molecule"><w c="NN">RXR</w></cons><w c=")">)</w> <w c="JJ">agonist-induced</w> <w c="NN">activation</w></cons> <w c="IN">of</w> <w c="JJ">dominant-negative</w> <cons lex="RXR" sem="G#protein_molecule"><w c="*">RXR</w></cons><w c="JJ">-retinoic</w> <w c="NN">acid</w> <w c="NN">receptor</w> <w c="NN">alpha403</w> <w c="NNS">heterodimers</w> <w c="VBZ">is</w> <w c="RB">developmentally</w> <w c="VBN">regulated</w> <w c="IN">during</w> <cons lex="myeloid_differentiation" sem="G#other_name"><w c="JJ">myeloid</w> <w c="NN">differentiation</w></cons><w c=".">.</w></sentence>
</title>
<abstract>
<sentence><w c="DT">The</w> <cons lex="multiple_biologic_activity" sem="G#other_name"><w c="JJ">multiple</w> <w c="JJ">biologic</w> <w c="NNS">activities</w></cons> <w c="IN">of</w> <cons lex="retinoic_acid" sem="G#other_organic_compound"><w c="JJ">retinoic</w> <w c="NN">acid</w></cons> <w c="(">(</w><cons lex="RA" sem="G#other_organic_compound"><w c="NN">RA</w></cons><w c=")">)</w> <w c="VBP">are</w> <w c="VBN">mediated</w> <w c="IN">through</w> <cons lex="RAR" sem="G#protein_family_or_group"><w c="NN">RAR</w></cons> <w c="CC">and</w> <cons lex="retinoid_X_receptor_(RXR)_nuclear_receptor" sem="G#protein_molecule"><w c="NN">retinoid</w> <w c="NN">X</w> <w c="NN">receptor</w> <w c="(">(</w><cons lex="RXR" sem="G#protein_molecule"><w c="NN">RXR</w></cons><w c=")">)</w> <w c="JJ">nuclear</w> <w c="NNS">receptors</w></cons> <w c="WDT">that</w> <w c="VBP">interact</w> <w c="IN">with</w> <w c="JJ">specific</w> <cons lex="DNA_target_sequence" sem="G#DNA_domain_or_region"><w c="NN">DNA</w> <w c="NN">target</w> <w c="VBZ">sequences</w></cons> <w c="IN">as</w> <cons lex="heterodimer" sem="G#protein_complex"><w c="NNS">heterodimers</w></cons> <w c="(">(</w><cons lex="RXR-RAR" sem="G#protein_complex"><w c="NN">RXR-RAR</w></cons><w c=")">)</w> <w c="CC">or</w> <cons lex="homodimer" sem="G#protein_complex"><w c="NNS">homodimers</w></cons> <w c="(">(</w><cons lex="RXR-RXR" sem="G#protein_complex"><w c="NN">RXR-RXR</w></cons><w c=")">)</w><w c=".">.</w></sentence>
<sentence><cons lex="RA" sem="G#other_organic_compound"><w c="NN">RA</w></cons> <w c="NN">receptor</w> <w c="NN">activation</w> <w c="VBZ">appears</w> <w c="JJ">critical</w> <w c="TO">to</w> <w c="VBG">regulating</w> <w c="JJ">important</w> <w c="NNS">aspects</w> <w c="IN">of</w> <cons lex="hematopoiesis" sem="G#other_name"><w c="NN">hematopoiesis</w></cons><w c=",">,</w> <w c="IN">since</w> <w c="VBG">transducing</w> <w c="DT">a</w> <cons lex="COOH-terminally_truncated_RARalpha" sem="G#protein_molecule"><w c="RB">COOH-terminally</w> <w c="VBN">truncated</w> <w c="NN">RARalpha</w></cons> <w c="VBG">exhibiting</w> <w c="JJ">dominant-negative</w> <w c="NN">activity</w> <w c="(">(</w><cons lex="RARalpha403" sem="G#protein_molecule"><w c="NN">RARalpha403</w></cons><w c=")">)</w> <w c="IN">into</w> <cons lex="normal_mouse_bone_marrow" sem="G#tissue"><w c="JJ">normal</w> <w c="NN">mouse</w> <w c="NN">bone</w> <w c="NN">marrow</w></cons> <w c="VBZ">generates</w> <cons lex="hematopoietic_growth_factor-dependent_cell_line" sem="G#cell_line"><w c="JJ">hematopoietic</w> <w c="NN">growth</w> <w c="JJ">factor-dependent</w> <w c="NN">cell</w> <w c="NNS">lines</w></cons> <w c="VBN">frozen</w> <w c="IN">at</w> <w c="DT">the</w> <cons lex="(OR multipotent_progenitor_(EML)_stage committed_promyelocyte_(MPRO)_stage)" sem="(OR G#other_name G#other_name)"><cons lex="multipotent_progenitor_(EML)*"><w c="JJ">multipotent</w> <w c="NN">progenitor</w> <w c="(">(</w><w c="NN">EML</w><w c=")">)</w></cons> <w c="CC">or</w> <cons lex="committed_promyelocyte_(MPRO)*"><w c="VBN">committed</w> <w c="JJ">promyelocyte</w> <w c="(">(</w><w c="NN">MPRO</w><w c=")">)</w></cons> <cons lex="*stage"><w c="NNS">stages</w></cons></cons><w c=".">.</w></sentence>
<sentence><w c="RB">Nevertheless</w><w c=",">,</w> <w c="RB">relatively</w> <w c="JJ">high</w><w c=",">,</w> <cons lex="pharmacological_concentration" sem="G#other_name"><w c="JJ">pharmacological</w> <w c="NNS">concentrations</w></cons> <w c="IN">of</w> <cons lex="RA" sem="G#other_organic_compound"><w c="NN">RA</w></cons> <w c="(">(</w><w c="CD">1</w> <w c="TO">to</w> <w c="CD">10</w> <w c="CC">&amp;</w><w c="NN">mgr</w><w c=":">;</w><w c="NN">M</w><w c=")">)</w> <w c="VBP">overcome</w> <w c="DT">these</w> <w c="NN">differentiation</w> <w c="NNS">blocks</w> <w c="CC">and</w> <w c="VBP">induce</w> <cons lex="terminal_granulocytic_differentiation" sem="G#other_name"><w c="JJ">terminal</w> <w c="JJ">granulocytic</w> <w c="NN">differentiation</w></cons> <w c="IN">of</w> <w c="DT">the</w> <cons lex="MPRO_promyelocyte" sem="G#cell_type"><w c="NN">MPRO</w> <w c="NNS">promyelocytes</w></cons> <w c="IN">while</w> <w c="VBG">potentiating</w> <cons lex="interleukin-3_(IL-3)-induced_commitment" sem="G#other_name"><cons lex="interleukin-3" sem="G#protein_molecule"><w c="NN">interleukin-3</w></cons> <w c="(">(</w><cons lex="IL-3" sem="G#protein_molecule"><w c="NN">IL-3</w></cons><w c=")">)</w><w c="JJ">-induced</w> <w c="NN">commitment</w></cons> <w c="IN">of</w> <cons lex="EML_cell" sem="G#cell_type"><w c="NN">EML</w> <w c="NNS">cells</w></cons> <w c="TO">to</w> <w c="DT">the</w> <w c="NN">granulocyte/monocyte</w> <w c="NN">lineage</w><w c=".">.</w></sentence>
<sentence><w c="IN">In</w> <w c="DT">the</w> <w c="JJ">present</w> <w c="NN">study</w><w c=",">,</w> <w c="PRP">we</w> <w c="VBD">utilized</w> <cons lex="RXR" sem="G#protein_molecule"><w c="*">RXR</w></cons> <w c="NN">-</w><w c="CC">and</w> <cons lex="RAR" sem="G#protein_family_or_group"><w c="*">RAR</w></cons><w c="JJ">-specific</w> <cons lex="agonist" sem="G#other_organic_compound"><w c="NNS">agonists</w></cons> <w c="CC">and</w> <cons lex="antagonist" sem="G#other_organic_compound"><w c="NNS">antagonists</w></cons> <w c="TO">to</w> <w c="VB">determine</w> <w c="WRB">how</w> <cons lex="RA" sem="G#other_organic_compound"><w c="NN">RA</w></cons> <w c="VBZ">overcomes</w> <w c="DT">the</w> <cons lex="dominant-negative_activity" sem="G#other_name"><w c="JJ">dominant-negative</w> <w c="NN">activity</w></cons> <w c="IN">of</w> <w c="DT">the</w> <cons lex="truncated_RARalpha" sem="G#protein_family_or_group"><w c="VBN">truncated</w> <w c="NN">RARalpha</w></cons> <w c="IN">in</w> <w c="DT">these</w> <w c="JJ">different</w> <cons lex="myeloid_developmental_stage" sem="G#other_name"><w c="JJ">myeloid</w> <w c="JJ">developmental</w> <w c="NNS">stages</w></cons><w c=".">.</w></sentence>
<sentence><w c="RB">Unexpectedly</w><w c=",">,</w> <w c="PRP">we</w> <w c="VBD">observed</w> <w c="IN">that</w> <w c="DT">an</w> <cons lex="RXR-specific_agonist" sem="G#other_organic_compound"><cons lex="RXR" sem="G#protein_molecule"><w c="*">RXR</w></cons><w c="JJ">-specific</w></cons><w c=",">,</w> <w c="RB">rather</w> <w c="IN">than</w> <w c="DT">an</w> <cons lex="RAR-specific_agonist" sem="G#other_organic_compound"><cons lex="RAR" sem="G#protein_family_or_group"><w c="*">RAR</w></cons><w c="JJ">-specific</w></cons><w c=",">,</w> <w c="NN">agonist</w> <w c="VBZ">induces</w> <cons lex="terminal_granulocytic_differentiation" sem="G#other_name"><w c="JJ">terminal</w> <w c="JJ">granulocytic</w> <w c="NN">differentiation</w></cons> <w c="IN">of</w> <cons lex="MPRO_promyelocyte" sem="G#cell_type"><w c="NN">MPRO</w> <w c="NNS">promyelocytes</w></cons><w c=",">,</w> <w c="CC">and</w> <w c="DT">this</w> <w c="NN">differentiation</w> <w c="VBZ">is</w> <w c="VBN">associated</w> <w c="IN">with</w> <w c="NN">activation</w> <w c="IN">of</w> <cons lex="DNA_response_element" sem="G#DNA_domain_or_region"><w c="NN">DNA</w> <w c="NN">response</w> <w c="NNS">elements</w></cons> <w c="VBG">corresponding</w> <w c="TO">to</w> <cons lex="RAR-RXR_heterodimer" sem="G#protein_complex"><w c="NN">RAR-RXR</w> <w c="NNS">heterodimers</w></cons> <w c="RB">rather</w> <w c="IN">than</w> <cons lex="RXR-RXR_homodimer" sem="G#protein_complex"><cons lex="RXR-RXR" sem="G#protein_complex"><w c="NN">RXR-RXR</w></cons> <w c="NNS">homodimers</w></cons><w c=".">.</w></sentence>
<sentence><w c="DT">This</w> <cons lex="RXR" sem="G#protein_molecule"><w c="NN">RXR</w></cons> <w c="NN">agonist</w> <w c="NN">activity</w> <w c="VBZ">is</w> <w c="VBN">blocked</w> <w c="IN">by</w> <cons lex="RAR-specific_antagonist" sem="G#other_organic_compound"><cons lex="RAR" sem="G#protein_family_or_group"><w c="*">RAR</w></cons><w c="JJ">-specific</w> <w c="NNS">antagonists</w></cons><w c=",">,</w> <w c="VBG">suggesting</w> <w c="JJ">extensive</w> <w c="NN">cross-talk</w> <w c="IN">between</w> <w c="DT">the</w> <w c="NNS">partners</w> <w c="IN">of</w> <w c="DT">the</w> <cons lex="RXR-_RARalpha403_heterodimer" sem="G#protein_complex"><cons lex="RXR" sem="G#protein_molecule"><w c="*">RXR</w></cons> <cons lex="RARalpha403" sem="G#protein_molecule"><w c="NN">-RARalpha403</w></cons> <w c="NN">heterodimer</w></cons><w c=".">.</w></sentence>
<sentence><w c="IN">In</w> <w c="NN">contrast</w><w c=",">,</w> <w c="IN">in</w> <w c="DT">the</w> <w c="RBR">more</w> <w c="JJ">immature</w><w c=",">,</w> <w c="JJ">multipotent</w> <cons lex="EML_cell" sem="G#cell_type"><w c="NN">EML</w> <w c="NNS">cells</w></cons> <w c="PRP">we</w> <w c="VBD">observed</w> <w c="IN">that</w> <w c="DT">this</w> <cons lex="RXR-specific_agonist" sem="G#other_organic_compound"><cons lex="RXR" sem="G#protein_molecule"><w c="*">RXR</w></cons><w c="JJ">-specific</w> <w c="NN">agonist</w></cons> <w c="VBZ">is</w> <w c="JJ">inactive</w> <w c="CC">either</w> <w c="IN">in</w> <w c="VBG">potentiating</w> <cons lex="IL-3-mediated_commitment" sem="G#other_name"><cons lex="IL-3" sem="G#protein_molecule"><w c="*">IL-3</w></cons><w c="JJ">-mediated</w> <w c="NN">commitment</w></cons> <w c="IN">of</w> <cons lex="EML_cell" sem="G#cell_type"><w c="NN">EML</w> <w c="NNS">cells</w></cons> <w c="TO">to</w> <w c="DT">the</w> <cons lex="granulocyte_lineage" sem="G#cell_type"><w c="NN">granulocyte</w> <w c="NN">lineage</w></cons> <w c="CC">or</w> <w c="IN">in</w> <w c="VBG">transactivating</w> <cons lex="RAR-RXR_response_element" sem="G#DNA_family_or_group"><w c="NN">RAR-RXR</w> <w c="NN">response</w> <w c="NNS">elements</w></cons><w c=".">.</w></sentence>
<sentence><cons lex="RA-_triggered_GALdbd-RARalpha_hybrid_activity" sem="G#other_name"><cons lex="RA" sem="G#other_organic_compound"><w c="*">RA</w></cons> <w c="JJ">-triggered</w> <w c="*">GALdbd-</w><cons lex="RARalpha" sem="G#protein_molecule"><w c="NN">RARalpha</w></cons> <w c="NN">hybrid</w> <w c="NN">activity</w></cons> <w c="IN">in</w> <w c="DT">these</w> <w c="NNS">cells</w> <w c="VBZ">indicates</w> <w c="IN">that</w> <w c="DT">the</w> <w c="JJ">multipotent</w> <cons lex="EML_cell" sem="G#cell_type"><w c="NN">EML</w> <w c="NNS">cells</w></cons> <w c="VBP">harbor</w> <w c="JJ">substantial</w> <cons lex="nuclear_hormone_receptor_coactivator_activity" sem="G#other_name"><w c="JJ">nuclear</w> <w c="NN">hormone</w> <w c="NN">receptor</w> <cons lex="coactivator" sem="G#protein_family_or_group"><w c="NN">coactivator</w></cons> <w c="NN">activity</w></cons><w c=".">.</w></sentence>
<sentence><w c="RB">However</w><w c=",">,</w> <w c="DT">the</w> <cons lex="histone_deacetylase_(HDAC)_inhibitor" sem="G#protein_family_or_group"><w c="NN">histone</w> <w c="NN">deacetylase</w> <w c="(">(</w><w c="NN">HDAC</w><w c=")">)</w> <w c="NN">inhibitor</w></cons> <cons lex="trichostatin_A" sem="G#other_organic_compound"><w c="NN">trichostatin</w> <w c="NN">A</w></cons> <w c="RB">readily</w> <w c="VBZ">activates</w> <w c="DT">an</w> <cons lex="RXR-RAR_reporter_construct" sem="G#DNA_molecule"><cons lex="RXR-RAR" sem="G#protein_complex"><w c="NN">RXR-RAR</w></cons> <w c="NN">reporter</w> <w c="NN">construct</w></cons> <w c="IN">in</w> <w c="DT">the</w> <w c="JJ">multipotent</w> <cons lex="EML_cell" sem="G#cell_type"><w c="NN">EML</w> <w c="NNS">cells</w></cons> <w c="CC">but</w> <w c="RB">not</w> <w c="IN">in</w> <w c="DT">the</w> <w c="VBN">committed</w> <cons lex="MPRO_promyelocyte" sem="G#cell_type"><w c="NN">MPRO</w> <w c="NNS">promyelocytes</w></cons><w c=",">,</w> <w c="VBG">indicating</w> <w c="IN">that</w> <w c="NNS">differences</w> <w c="IN">in</w> <cons lex="HDAC-containing_repressor_complex" sem="G#protein_complex"><w c="JJ">HDAC-containing</w> <w c="NN">repressor</w> <w c="NNS">complexes</w></cons> <w c="IN">in</w> <w c="DT">these</w> <w c="CD">two</w> <w c="RB">closely</w> <w c="JJ">related</w> <w c="CC">but</w> <w c="JJ">distinct</w> <cons lex="hematopoietic_lineage" sem="G#cell_type"><w c="JJ">hematopoietic</w> <w c="NNS">lineages</w></cons> <w c="MD">might</w> <w c="VB">account</w> <w c="IN">for</w> <w c="DT">the</w> <w c="JJ">differential</w> <w c="NN">activation</w> <w c="IN">of</w> <w c="DT">the</w> <cons lex="RXR-RARalpha403_heterodimer" sem="G#protein_complex"><w c="NN">RXR-RARalpha403</w> <w c="NNS">heterodimers</w></cons> <w c="WDT">that</w> <w c="PRP">we</w> <w c="VBD">observed</w> <w c="IN">at</w> <w c="DT">these</w> <w c="JJ">different</w> <w c="NNS">stages</w> <w c="IN">of</w> <cons lex="myeloid_development" sem="G#other_name"><w c="JJ">myeloid</w> <w c="NN">development</w></cons><w c=".">.</w></sentence>
</abstract>
</article>
